A New Early Predictor of Fatal Outcome for COVID-19 in an Italian Emergency Department: The Modified Quick-SOFA.

COVID-19 MqSOFA NEWS2 SARS-CoV-2 in-hospital mortality nCOV19

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
12 Apr 2022
Historique:
received: 18 03 2022
revised: 12 04 2022
accepted: 12 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 24 4 2022
Statut: epublish

Résumé

Background: Since 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing a rapidly spreading pandemic. The present study aims to compare a modified quick SOFA (MqSOFA) score with the NEWS-2 score to predict in-hospital mortality (IHM), 30-days mortality and recovery setting. Methods: All patients admitted from March to October 2020 to the Emergency Department of St. Anna Hospital, Ferrara, Italy with clinically suspected SARS-CoV-2 infection were retrospectively included in this single-centre study and evaluated with the MqSOFA and NEWS-2 scores. Statistical and logistic regression analyses were applied to our database. Results: A total of 3359 individual records were retrieved. Among them, 2716 patients were excluded because of a negative nasopharyngeal swab and 206 for lacking data; thus, 437 patients were eligible. The data showed that the MqSOFA and NEWS-2 scores equally predicted IHM (p < 0.001) and 30-days mortality (p < 0.001). Higher incidences of coronary artery disease, congestive heart failure, cerebrovascular accidents, dementia, chronic kidney disease and cancer were found in the deceased vs. survived group. Conclusions: In this study we confirmed that the MqSOFA score was non-inferior to the NEWS-2 score in predicting IHM and 30-days mortality. Furthermore, the MqSOFA score was easier to use than NEWS-2 and is more suitable for emergency settings. Neither the NEWS-2 nor the MqSOFA scores were able to predict the recovery setting.

Identifiants

pubmed: 35456856
pii: microorganisms10040806
doi: 10.3390/microorganisms10040806
pmc: PMC9032690
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Korean Med Sci. 2020 Jun 29;35(25):e234
pubmed: 32597046
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1731-1734
pubmed: 34914670
Infection. 2022 Feb 18;:
pubmed: 35179719
JAMA. 2020 Sep 8;324(10):998-1000
pubmed: 32789492
Int J Infect Dis. 2022 Mar;116:38-42
pubmed: 34971823
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32817205
Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):825-831
pubmed: 33118057
Eur Respir Rev. 2020 Nov 5;29(158):
pubmed: 33153991
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264
pubmed: 32235085
Front Immunol. 2020 Nov 30;11:598404
pubmed: 33329592
Am J Emerg Med. 2020 Oct;38(10):2074-2080
pubmed: 33142178
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Infection. 2021 Feb;49(1):15-28
pubmed: 32860214
Lancet Infect Dis. 2022 Jan;22(1):35-42
pubmed: 34461056
Intensive Care Med. 2020 May;46(5):854-887
pubmed: 32222812
Viruses. 2021 Aug 25;13(9):
pubmed: 34578269
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2103-2109
pubmed: 33161221
J Community Health. 2020 Dec;45(6):1270-1282
pubmed: 32918645
Crit Care Med. 2021 Mar 1;49(3):e219-e234
pubmed: 33555780
Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520947505
pubmed: 32812440
Eur J Heart Fail. 2020 Dec;22(12):2205-2215
pubmed: 32833283
Oncologist. 2021 Jan;26(1):
pubmed: 32845538
Eur Respir J. 2020 Sep 10;56(3):
pubmed: 32675205
BMC Med. 2021 Jan 21;19(1):23
pubmed: 33472631
Respir Med. 2013 Jun;107(6):789-99
pubmed: 23490227
Scand J Trauma Resusc Emerg Med. 2020 Jul 13;28(1):66
pubmed: 32660623
Biomedicines. 2021 Aug 18;9(8):
pubmed: 34440240
Resuscitation. 2020 Nov;156:84-91
pubmed: 32918985
Am J Kidney Dis. 2021 Feb;77(2):190-203.e1
pubmed: 32961244
Eur Heart J. 2020 May 14;41(19):1821-1829
pubmed: 32383763
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264

Auteurs

Matteo Guarino (M)

Department of Translational Medicine, St. Anna University Hospital of Ferrara, University of Ferrara, 44121 Ferrara, Italy.

Benedetta Perna (B)

Department of Translational Medicine, St. Anna University Hospital of Ferrara, University of Ferrara, 44121 Ferrara, Italy.

Francesca Remelli (F)

Department of Medical Sciences, St. Anna University Hospital of Ferrara, University of Ferrara, 44121 Ferrara, Italy.

Francesca Cuoghi (F)

Department of Translational Medicine, St. Anna University Hospital of Ferrara, University of Ferrara, 44121 Ferrara, Italy.

Alice Eleonora Cesaro (AE)

Department of Translational Medicine, St. Anna University Hospital of Ferrara, University of Ferrara, 44121 Ferrara, Italy.

Michele Domenico Spampinato (MD)

Department of Translational Medicine, St. Anna University Hospital of Ferrara, University of Ferrara, 44121 Ferrara, Italy.

Martina Maritati (M)

Infectious and Dermatology Diseases, St. Anna University Hospital of Ferrara, University of Ferrara, 44121 Ferrara, Italy.

Carlo Contini (C)

Infectious and Dermatology Diseases, St. Anna University Hospital of Ferrara, University of Ferrara, 44121 Ferrara, Italy.

Roberto De Giorgio (R)

Department of Translational Medicine, St. Anna University Hospital of Ferrara, University of Ferrara, 44121 Ferrara, Italy.

Classifications MeSH